Domov › Rakovina močového mechúra › Tennessee › Nashville
Klinické štúdie Rakovina močového mechúra v meste Nashville, TN
31 štúdií pre Rakovina močového mechúra hľadá účastníkov v zariadeniach v meste Nashville a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Prebieha náborFáza 1
- Sarah Cannon Research Institute, Nashville
- Tennessee Oncology PLLC, Nashville
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Prebieha náborFáza 2
- SCRI Oncology Partners, Nashville
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Prebieha náborFáza 2
- SCRI Oncology Partners, Nashville
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Prebieha náborFáza 1
- Sarah Cannon Research Institute - Pharmacy, Nashville
- SCRI Oncology Partners, Nashville
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Prebieha náborFáza 2
- Vanderbilt University/Ingram Cancer Center, Nashville
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
Prebieha náborFáza 3
- SCRI Oncology Partners, Nashville
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Prebieha náborFáza 1/2
- Sarah Cannon Research Institute, Nashville
- SCRI Oncology Partners, Nashville
- Tennessee Oncology, PLLC - Elliston Place Plaza Medical Oncology & Hematology, Nashville
- a 9 ďalších
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Prebieha náborFáza 1
- Sarah Cannon Research Institute, Nashville
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Prebieha náborFáza 1
- Urology Associates, P.C., Nashville
DESTINY-PANTUMOUR04
Prebieha náborObservačná štúdia
- Research Site, Nashville
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
Prebieha náborFáza 3
- Tennessee Oncology, PLLC - Elliston Place Plaza Medical Oncology & Hematology ( Site 0831), Nashville
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Prebieha náborFáza 3
- Sarah Cannon Research Institute, Nashville
- SCRI Oncology Partners, Nashville
- Tennessee Oncology, Nashville
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Prebieha náborFáza 1/2
- Sarah Cannon Research Institute, Nashville
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
Prebieha náborFáza 1
- SCRI, Nashville
- Vanderbilt-Ingram Cancer Center, Nashville
First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
Prebieha náborFáza 1
- Sarah Cannon Research Institute, Nashville
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Prebieha náborFáza 2
- Urology Associates, PC, Nashville
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Prebieha náborFáza 2
- Urology Associates PC, Nashville
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Prebieha náborFáza 2/3
- Research Site, Nashville
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Prebieha náborFáza 1
- Sarah Cannon and HCA Research Institute, Nashville
- Tennessee Oncology, Nashville
- Vanderbilt University Medical Center, Nashville
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Prebieha náborFáza 3
- Vanderbilt Breast Center at One Hundred Oaks, Nashville
- Vanderbilt University/Ingram Cancer Center, Nashville
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Prebieha náborFáza 1/2
- Sarah Cannon Research Institute Oncology Partners (SCRI-Nashville), Nashville
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Prebieha náborFáza 1/2
- Urology Associates, P.C., Nashville
- Vanderbilt Univerity Medical Center, Nashville
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
Prebieha náborObservačná štúdia
- Vanderbilt University Medical Center, Nashville
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Prebieha náborFáza 2/3
- SCRI Oncology Partners, Nashville
- Local Institution - 0084, Nashville
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Prebieha náborFáza 2
- SCRI - TriStar Medical Group Children's Specialists, Nashville
- SCRI Oncology Partners, Nashville
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
Prebieha náborFáza 3
- Research Site, Nashville
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Prebieha náborFáza 1
- US Oncology Research LLC, Nashville
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Prebieha nábor
- Vanderbilt University Medical Center, Nashville
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Prebieha náborFáza 1
- Sarah Cannon Research Institute (SCRI) Oncology Partners, Nashville
- Vanderbilt University Medical Center, Nashville
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Vanderbilt-Ingram Cancer Center, Nashville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Prebieha náborObservačná štúdia
- Massive Bio SYNERGY-AI site, Nashville
Štúdie Rakovina močového mechúra v iných mestách
- New York City, NY35 štúdií
- Houston, TX31 štúdií
- Dallas, TX27 štúdií
- Washington, DC26 štúdií
- Boston, MA26 štúdií
- Baltimore, MD24 štúdií
- Los Angeles, CA24 štúdií
- St. Louis, MO22 štúdií
- Seattle, WA21 štúdií
- Chicago, IL21 štúdií
- Philadelphia, PA21 štúdií
- Edison, NJ21 štúdií
Iné štúdie v Nashville
- Nemalobunkový karcinóm pľúc97 štúdií
- Rakovina prsníka81 štúdií
- Metastatická rakovina70 štúdií
- Kolorektálny karcinóm69 štúdií
- Rakovina (všetky typy)65 štúdií
- Rakovina vaječníkov49 štúdií
- Rakovina prostaty43 štúdií
- Rakovina pľúc40 štúdií
- Skvamóznocelulárny karcinóm hlavy a krku39 štúdií
- Rakovina pankreasu39 štúdií
- Rakovina endometria38 štúdií
- Melanóm33 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.